Treatment Options

High Sensitivity C-Reactive Protein Testing for Cardiovascular Disease

Possible Harm/No Value

C-reactive protein (CRP) is produced by the liver.  CRP is a classic acute-phase reactant protein.  Under normal conditions CRP is found in low levels in the blood.  Levels of CRP can increase in response to inflammatory conditions, infections and other diseases where tissue death occurs.  CRP is not a specific marker of inflammation.  Levels of CRP can fluctuate a lot from day to day.  Blood specimens for CRP are collected by venipuncture.

Conventional methods for measuring CRP in acute inflammatory diseases have a detection limit of 3 - 5 mg/L.  The average CRP reading in this country is 1.5 mg/L, with lower levels being a possible indication of chronic inflammation. High sensitivity CRP (hs-CRP) immunoassays can measure levels of CRP as low as 0.175 mg/L.  An hs-CRP elevation can be caused by inflammatory conditions and, therefore, are not specific for individual cardiovascular disease (CVD) assessment.  The results of these hs-CRP assays are being investigated in various settings for a possible association with cardiovascular disease (e.g., screening, diagnosis and management).

Things to Consider

  • The extent to which hs-CRP provides extra prediction of CVD beyond all the major risk factors combined is not known.
  • An hs-CRP elevation can be caused by inflammatory conditions and, therefore are not specific for individual cardiovascular assessment.

Results

Possible Harm/No Value

Will I live longer if I have this procedure?

Well-designed, randomized, controlled trials with long-term follow-up are not available to determine long-term benefits of the use of hs-CRP testing for the screening, diagnosis, and management of cardiovascular disease.

Will the treatment of endometriosis improve my quality of life?

Long-term scientific evidence is not available to show whether hs-CRP testing will improve your quality of life.

Safety

How safe is this for me?

Possible Harm/No Value

Currently, the safety of hs-CRP testing is not available.

Comparison

Possible Harm/No Value

Much more information is needed before comparisons can be made regarding what, if any extent hs-CRP testing provides extra prediction of CVD beyond all the major risk factors combined.

Cost

Possible Harm/No ValueThe cost of hs-CRP testing for cardiovascular disease is approximately $50, depending on which laboratory is used.

The cost may or may not be covered by your health benefits plan.

Sources

The following are off-site links off-site link :

Institute for Clinical Systems Improvement. (2003, January). Biochemical markers of cardiovascular disease risk. Retrieved May 21, 2007 from http://www.icsi.org/technology_assessment_reports_-_active/ta_biochemical_markers_of_cardiovascular_disease_risk.html. 

MedlinePlus. (2009, February). C-reactive protein. Retrieved August 11, 2009 from http://www.nlm.nih.gov/medlineplus/ency/article/003356.htm.

Next Review Date

08/11/2010

This document has been classified as public information.

Table of Findings

results:  possible harm / no value

safety:  possible harm / no value

comparison:  possible harm / no value

cost: possible harm / no value


total: possible harm / no value

legend

scale

Page modified:September 4, 2009